Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Preventive Services and Health Promotion Research Network | OTHER |
| Catalan Institute of Health | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
OBJECTIVE: To evaluate the impact of an intervention addressed to health professionals to improve the adequacy of lipid-lowering prescription in primary prevention of cardiovascular disease and reducing expenditure in this respect.
DESIGN: a cluster randomized clinical trial, not blind; Data were obtained from medical records and other primary care databases.
SETTING: 279 primary health care teams in Catalonia (Spain), centers managed by Catalan Health Institute (ICS)
SUBJECTS: Population from 35 to 74 years, free of cardiovascular disease, who have been started on lipid-lowering therapy during 2 consecutive years of study.
INTERVENTION: Practitioners in the intervention group may have access, whenever they want and through the computerized medical record program, to personalized information on their assigned patients who have started treatment of cardiovascular primary prevention with lipid-lowering. This information is updated monthly for 12 consecutive months.Information will be presented in two different and complementary ways to each practitioner: asynchronous information (the patient is not present when the practitioner receives the information) and synchronous information (the patient is present when the practitioner receives the information).
VARIABLES:
Primary Outcomes are:
Secondary Outcomes are:
2.Other variables:
STATISTICAL ANALYSIS: Descriptive analysis, agreggated at health professional level, will be performed and subsequently multilevel analysis techniques will be used to estimate the effect of intervention according to hierarchic data structure and, in particular, patient variables effect.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Information Support System | Experimental | Practitioners in the intervention group may have access, whenever they want and through the computerized medical record program, to personalized information on their assigned patients who have started treatment of cardiovascular primary prevention with lipid-lowering. |
|
| Control group | No Intervention | Routine clinical practice |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Information Support System | Other | Practitioners in the intervention group may have access, whenever they want and through the computerized medical record program, to personalized information on their assigned patients who have started treatment of cardiovascular primary prevention with lipid-lowering. This information is updated monthly for 12 consecutive months.Information will be presented in two different and complementary ways to each practitioner: asynchronous information (the patient is not present when the practitioner receives the information) and synchronous information (the patient is present when the practitioner receives the information). |
| Measure | Description | Time Frame |
|---|---|---|
| percentage of participants with increase of the adequacy of lipid-lowering prescription | The primary outcome is the improvement in the appropriateness of prescribing of lipid-lowering therapy in primary prevention as recommended by the guide clinical practice intervention in the Institut Català de la Salut compared with clinical practice group. To answer the main objective of the study, two dependent variables were calculated:
| up to 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| percentage of patients with cardiovascular risk register in the clinical records of patients | To assess the degree of cardiovascular risk register in the clinical records of patients RECORD variable is calculated: Variable RECORD: recording of the cardiovascular risk | up to 24 months |
| Change from baseline in the total cost of the lipid-lowering treatments prescribed during the study period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bonaventura BolÃbar | Jordi Gol i Gurina Foundation - IDIAP Jordi Gol | Principal Investigator |
| Sebastià Calero | Catalan Institute of Health | Study Chair |
| Josep Casajuana | Catalan Institute of Health | Study Chair |
| Ermengol Coma | Catalan Institute of Health | Study Chair |
| Francesc Fina | Catalan Institute of Health | Study Chair |
| Mireia FÃ bregas | Catalan Institute of Health | Study Chair |
| Eduardo Hermosilla | Jordi Gol i Gurina Foundation - IDIAP Jordi Gol | Study Chair |
| Manolo Medina | Catalan Institute of Health | Study Chair |
| Mònica Monteagudo | Jordi Gol i Gurina Foundation - IDIAP Jordi Gol | Study Chair |
| Rosa Morros |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IDIAP Jordi Gol | Barcelona | Barcelona | 08007 | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25027229 | Derived | Fabregas M, Berges I, Fina F, Hermosilla E, Coma E, Mendez L, Medina M, Calero S, Serrano E, Morros R, Monteagudo M, Bolibar B. Effectiveness of an intervention designed to optimize statins use: a primary prevention randomized clinical trial. BMC Fam Pract. 2014 Jul 15;15:135. doi: 10.1186/1471-2296-15-135. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
to assess the economic impact of the new primary prevention lipid-lowering treatments prescribed during the study period. To be determined by variable COST Variable COST: total cost of the inadequate new lipid-lowering treatments |
| baseline, months 24 |
| Jordi Gol i Gurina Foundation - IDIAP Jordi Gol |
| Study Chair |
| Magdalena Rosell | Jordi Gol i Gurina Foundation - IDIAP Jordi Gol | Study Chair |